206 related articles for article (PubMed ID: 33760984)
1. High KIFC1 expression is associated with poor prognosis in prostate cancer.
Kostecka LG; Olseen A; Kang K; Torga G; Pienta KJ; Amend SR
Med Oncol; 2021 Mar; 38(5):47. PubMed ID: 33760984
[TBL] [Abstract][Full Text] [Related]
2. A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas.
Mittal K; Choi DH; Klimov S; Pawar S; Kaur R; Mitra AK; Gupta MV; Sams R; Cantuaria G; Rida PCG; Aneja R
J Ovarian Res; 2016 Mar; 9():17. PubMed ID: 26992853
[TBL] [Abstract][Full Text] [Related]
3. KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries.
Pawar S; Donthamsetty S; Pannu V; Rida P; Ogden A; Bowen N; Osan R; Cantuaria G; Aneja R
J Ovarian Res; 2014; 7():53. PubMed ID: 25028599
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of kinesin motor protein KIFC1 by AZ82 induces multipolar mitosis and apoptosis in prostate cancer cell.
Parvin A; Hao SL; Tan FQ; Yang WX
Gene; 2020 Nov; 760():144989. PubMed ID: 32717307
[TBL] [Abstract][Full Text] [Related]
5. Expression of kinesin family member C1 in pancreatic ductal adenocarcinoma affects tumor progression and stemness.
Ishikawa A; Fujii H; Fukui T; Kido A; Katsuya N; Sentani K; Kuraoka K; Tazuma S; Sudo T; Serikawa M; Oka S; Oue N
Pathol Res Pract; 2023 Jan; 241():154277. PubMed ID: 36565617
[TBL] [Abstract][Full Text] [Related]
6. KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma.
Fu X; Zhu Y; Zheng B; Zou Y; Wang C; Wu P; Wang J; Chen H; Du P; Liang B; Fang L
Int J Oncol; 2018 Jun; 52(6):1912-1922. PubMed ID: 29620256
[TBL] [Abstract][Full Text] [Related]
7. Kinesin Family Member C1 (KIFC1/HSET) Underlies Aggressive Disease in Androgen Receptor-Low and Basal-Like Triple-Negative Breast Cancers.
Jinna N; Yuan YC; Rida P
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003261
[TBL] [Abstract][Full Text] [Related]
8. Increased expression levels of AURKA and KIFC1 are promising predictors of progression and poor survival associated with gastric cancer.
Jung J; Jeong H; Choi JW; Kim HS; Oh HE; Lee ES; Kim YS; Lee JH
Pathol Res Pract; 2021 Aug; 224():153524. PubMed ID: 34148003
[TBL] [Abstract][Full Text] [Related]
9. KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer.
Sekino Y; Oue N; Shigematsu Y; Ishikawa A; Sakamoto N; Sentani K; Teishima J; Matsubara A; Yasui W
Urol Oncol; 2017 Jan; 35(1):31.e13-31.e20. PubMed ID: 27665358
[TBL] [Abstract][Full Text] [Related]
10. KIFC1 regulates ZWINT to promote tumor progression and spheroid formation in colorectal cancer.
Akabane S; Oue N; Sekino Y; Asai R; Thang PQ; Taniyama D; Sentani K; Yukawa M; Toda T; Kimura KI; Egi H; Shimizu W; Ohdan H; Yasui W
Pathol Int; 2021 Jul; 71(7):441-452. PubMed ID: 33819373
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive analysis of the prognostic and immunotherapeutic characteristics of KIFC1 in pan-cancer and its role in the malignant phenotype of pancreatic cancer.
Zhang S; Qin O; Xu H; Wu S; Huang W; Song H
Aging (Albany NY); 2023 Dec; 15(24):14845-14863. PubMed ID: 38112634
[TBL] [Abstract][Full Text] [Related]
12. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.
Xiao KH; Teng K; Ye YL; Tan L; Chen MK; Liang HT; Feng ZH; Duan JL; Deng MH; Wei WS; Luo JH; Qin ZK; Xie D
Cancer Sci; 2019 Sep; 110(9):2822-2833. PubMed ID: 31278883
[TBL] [Abstract][Full Text] [Related]
13. KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity.
Teng K; Wei S; Zhang C; Chen J; Chen J; Xiao K; Liu J; Dai M; Guan X; Yun J; Xie D
J Exp Clin Cancer Res; 2019 Jul; 38(1):329. PubMed ID: 31340839
[TBL] [Abstract][Full Text] [Related]
14. Kinesin 12 (KIF15) contributes to the development and tumorigenicity of prostate cancer.
Qureshi Z; Ahmad M; Yang WX; Tan FQ
Biochem Biophys Res Commun; 2021 Oct; 576():7-14. PubMed ID: 34474246
[TBL] [Abstract][Full Text] [Related]
15. Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer.
Zhang Z; Chai C; Shen T; Li X; Ji J; Li C; Shang Z; Niu Y
Dis Markers; 2019; 2019():4782730. PubMed ID: 31565099
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinicopathological significance of kinesin family member C1 in various cancers: A meta-analysis.
Sun Y; Zhang Y; Lang Z; Huang J; Zou Z
Medicine (Baltimore); 2019 Oct; 98(40):e17346. PubMed ID: 31577729
[TBL] [Abstract][Full Text] [Related]
17. Kinesin Family Member C1 Overexpression Exerts Tumor-Promoting Properties in Head and Neck Squamous Cell Carcinoma via the Rac1/Wnt/β-catenin Pathway.
Yu BY; Shi LG; Jiang C; Wang GK; Liu J; Wu TY
Lab Invest; 2023 Jul; 103(7):100134. PubMed ID: 36990154
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer.
Chen C; Cai Z; Zhuo Y; Xi M; Lin Z; Jiang F; Liu Z; Wan Y; Zheng Y; Li J; Zhou X; Zhu J; Zhong W
BMC Cancer; 2020 Apr; 20(1):289. PubMed ID: 32252682
[TBL] [Abstract][Full Text] [Related]
19. Kinesin Motor Protein KIFC1 Is a Target Protein of miR-338-3p and Is Associated With Poor Prognosis and Progression of Renal Cell Carcinoma.
Li G; Chong T; Yang J; Li H; Chen H
Oncol Res; 2018 Dec; 27(1):125-137. PubMed ID: 29562961
[TBL] [Abstract][Full Text] [Related]
20. KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer.
Sekino Y; Oue N; Koike Y; Shigematsu Y; Sakamoto N; Sentani K; Teishima J; Shiota M; Matsubara A; Yasui W
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30744126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
